首页> 外国专利> SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY

SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY

机译:组氨酸去乙酰化酶1和2的选择性抑制作为心脏肥大的治疗方法

摘要

The present invention provides for methods of treating and preventing cardiac hypertrophy. Class I HDACs, which are known to participate in regulation of chromatin structure and gene expression, have generally been considered as pro-hypertrophic in their action. However, the present invention demonstrates that inhibition of certain Class I HDACs should be avoided in the treatment of cardiac hypertrophy, thereby pointing toward selective, and not global, inhibition of Class I HDACs. In particular, the present invention provides for selective inhibition of HDACs 1 and/or 2, and the avoidance of inhibition of HDAC3.
机译:本发明提供了治疗和预防心脏肥大的方法。众所周知,I类HDAC参与染色质结构和基因表达的调节,通常被认为是促肥大的。然而,本发明证明在心脏肥大的治疗中应避免对某些I类HDAC的抑制,从而指向对I类HDAC的选择性而非整体抑制。特别地,本发明提供了对HDAC 1和/或2的选择性抑制,以及避免了对HDAC3的抑制。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号